Topical treatments for atopic dermatitis
Pro Research Analysisby 
Searched over 200M research papers
Mainstay Topical Treatments for Atopic Dermatitis: Corticosteroids and Calcineurin Inhibitors
Topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) are the primary topical treatments for atopic dermatitis (AD). TCS are highly effective for reducing inflammation and controlling flares, with moderate-potency (group 5) corticosteroids showing strong results in improving symptoms and maintaining disease control. TCIs, such as pimecrolimus and tacrolimus, are also effective, especially for sensitive skin areas or when long-term use is needed to avoid steroid-related side effects. Both TCS and TCIs are not recommended for continuous long-term use due to potential safety concerns, but they remain the cornerstone of topical AD management for most patients Chu2023Sideris2022Uddin2023+5 MORE.
New and Emerging Topical Therapies: JAK Inhibitors, PDE-4 Inhibitors, and Aryl Hydrocarbon Receptor Agonists
Recent advances have introduced new classes of topical treatments for AD. Janus kinase (JAK) inhibitors, such as ruxolitinib and delgocitinib, have shown promising efficacy in reducing inflammation and itch, with ruxolitinib being among the most recently approved options. Phosphodiesterase-4 (PDE-4) inhibitors, like crisaborole and difamilast, offer moderate effectiveness and are generally well-tolerated. Tapinarof, an aryl hydrocarbon receptor agonist, is another novel agent demonstrating good efficacy in clinical trials. These new treatments provide alternatives for patients who do not respond well to traditional therapies or who require long-term management with a lower risk of side effects Chu2023Sideris2022Uddin2023+5 MORE.
Supportive and Adjunctive Topical Therapies: Emollients and Moisturizers
Moisturizers and emollients are strongly recommended as foundational therapy for all patients with AD. They help restore the skin barrier, reduce dryness, and can decrease the frequency and severity of flares. Regular use of moisturizers is essential, regardless of disease severity, and can enhance the effectiveness of other topical treatments Mayba2017Lazar2024Sidbury2023.
Limited Role of Topical Antibiotics and Antimicrobials
Topical antibiotics, whether used alone or in combination with other agents, are among the least effective options for managing AD and are generally not recommended for routine use. Similarly, topical antimicrobials, antiseptics, and antihistamines are not advised due to limited benefit and potential for harm Chu2023Sidbury2023.
Long-Term Management and Proactive Strategies
Proactive, intermittent use of TCS or TCIs can help maintain disease control and prevent relapses. This approach may reduce the need for continuous high-potency steroid use and minimize side effects. However, more research is needed to determine the best long-term strategies, especially with newer agents Mayba2017Sidbury2023.
Ongoing Research and Future Directions
There are over 30 new topical compounds in development, targeting various pathways involved in AD. While early results are promising, larger and longer-term studies are needed to fully assess their safety and effectiveness compared to established treatments. The expanding range of topical therapies offers hope for more personalized and effective management of AD in the future Sideris2022Freitas2022Kleinman2022+1 MORE.
Conclusion
Topical corticosteroids and calcineurin inhibitors remain the mainstay of atopic dermatitis treatment, with new options like JAK inhibitors, PDE-4 inhibitors, and aryl hydrocarbon receptor agonists expanding the therapeutic landscape. Moisturizers are essential for all patients, while topical antibiotics and antimicrobials have limited roles. Ongoing research continues to bring new hope for safer and more effective topical therapies for AD.
Sources and full results
Most relevant research papers on this topic